01 1Amphastar Pharmaceuticals
01 1BECLOMETHASONE DIPROPIONATE
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2015-01-05
Pay. Date : 2014-03-14
DMF Number : 27837
Submission : 2014-03-06
Status : Active
Type : II
20
Amphastar Nanjing Pharmaceuticals Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is BECLOMETHASONE DIPROPIONATE, with a corresponding US DMF Number 27837.
Remarkably, this DMF maintains an Active status since its submission on March 06, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 05, 2015, and payment made on March 14, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II
